Moneta Group Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,929
Closed -$251K 842
2025
Q4
$251K Buy
+4,929
New +$252K ﹤0.01% 689
2025
Q3
Sell
-3,136
Closed -$216K 806
2025
Q2
$216K Sell
3,136
-924
-23% -$62.9K ﹤0.01% 650
2025
Q1
$282K Sell
4,060
-182
-4% -$15K ﹤0.01% 539
2024
Q4
$365K Sell
4,242
-824
-16% -$89.1K 0.01% 492
2024
Q3
$603K Buy
5,066
+361
+8% +$48.1K 0.01% 370
2024
Q2
$672K Buy
4,705
+1,308
+39% +$173K 0.01% 333
2024
Q1
$436K Buy
+3,397
New +$404K 0.01% 405
2023
Q2
Sell
-2,552
Closed -$203K 564
2023
Q1
$203K Buy
+2,552
New +$181K ﹤0.01% 498
2018
Q4
Sell
-111,390
Closed -$2.63M 236
2018
Q3
$2.63M Sell
111,390
-44
-0% -$1.07K 0.27% 64
2018
Q2
$2.57M Buy
111,434
+834
+0.8% +$19.8K 0.29% 58
2018
Q1
$2.72M Hold
110,600
0.36% 45
2017
Q4
$2.97M Sell
110,600
-30,000
-21% -$763K 0.45% 31
2017
Q3
$3.38M Hold
140,600
0.53% 28
2017
Q2
$3.02M Hold
140,600
0.49% 32
2017
Q1
$2.41M Buy
140,600
+600
+0.4% +$10.4K 0.48% 29
2016
Q4
$2.51M Sell
140,000
-600
-0.4% -$10.9K 0.51% 28
2016
Q3
$2.92M Hold
140,600
0.66% 25
2016
Q2
$3.78M Hold
140,600
0.83% 20
2016
Q1
$3.81M Hold
140,600
0.85% 20
2015
Q4
$4.08M Hold
140,600
1% 20
2015
Q3
$3.81M Buy
+140,600
New +$3.98M 1.06% 19

Other funds holding NVO

Moneta Group Investment Advisors's NVO Position: Q1 2026 in Review

Moneta Group Investment Advisors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,929 shares — an estimated $251K sold.

Moneta Group Investment Advisors first reported a position in NVO in Q3 2015 and held it in 21 quarters. The position peaked at $4.08M in Q4 2015. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Moneta Group Investment Advisors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 4,929 Novo Nordisk shares in Q1 2026, an estimated $251K.
  • Moneta Group Investment Advisors first reported a position in Novo Nordisk in Q3 2015 and held it in 21 quarters.
  • Moneta Group Investment Advisors's Novo Nordisk position peaked at $4.08M in Q4 2015.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.